
67th Annual Scientific Meeting In-person Evaluation
The American Headache Society’s Annual Scientific Meeting continues to be the premiere venue for disseminating the latest and most up-to-date research and scientific advances underlying the practice of Headache Medicine. AHS has dedicated over 60 years to leading and serving the headache community.
Course Instructions
AHS members should login using their membership credentials, and all others can create a new Visitor account or login as a Visitor using their existing visitor credentials. Once logged in, click "Take Course" to complete the meeting evaluation and claim CME.
Target Audience
The Annual Scientific Meeting is designed for physicians, psychologists, scientists, researchers, physician assistants, nurse practitioners, and other health professionals involved in the care of patients with head, neck, and orofacial pain.
Learning Objectives
At the conclusion of the American Headache Society's 67th Annual Scientific Meeting, participants will report their intention to:
- Appraise the current state of headache research and explore future directions for the field
- Examine how psychological trauma affects headache
- Evaluate the science of sleep and light and their impact on headache medicine
- Discuss the current state of refractory headache research
Disclosure Information
The planners and faculty for this activity did not have any relationships to disclose unless listed below. All relevant relationships were mitigated prior to the start of the activity according to ACCME Standards.
PURPOSE/OBJECTIVE
At the conclusion of this activity, participants will report their intention to consider the association between headache, psychological trauma, sleep, and light when caring for patients with headache, and use applicable therapies to treat migraine, particularly refractory migraine.
ACCREDITATION STATEMENT
The American Headache Society® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
The American Headache Society® designates this Live activity for a maximum of 25.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABPN
THE AMERICAN BOARD OF PSYCHIATRY AND NEUROLOGY HAS REVIEWED THE 67th ANNUAL SCIENTIFIC MEETING AND HAS APPROVED THIS ACTIVITY AS PART OF A COMPREHENSIVE SELF-ASSESSMENT (SA) CME ACTIVITY, WHICH IS MANDATED BY THE ABMS AS A NECESSARY COMPONENT OF CONTINUING CERTIFICATION.
This activity awards up to 25.25 Category 1 CME which are approved as Self-Assessment CME credits. The approval period is for June 19 - 22, 2025.
AAFP
The AAFP has reviewed 67th Annual Scientific Meeting and deemed it acceptable for up to 30.75 Live AAFP Elective credits. Term of Approval is from 06/19/2025 to 06/22/2025. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PHARMACOLOGY
This content has been reviewed for pharmacology hours and the calculated value is: 2 hours of pharmacology content.
INSTRUCTIONS FOR CLAIMING CME:
- Login/create a new visitor account (when creating an account, please be sure to use the email address you used during registration for the Annual Meeting).
- Complete the post-activity evaluation.
- For ABPN Self-Assessment Credit, complete the short ABPN Self-Assessment Quiz.
- Enter the number of CME credits being claimed* per credit type.
- Download your certificate. Certificates will only be issued for AMA PRA Category 1 Credit (MDs/DOs) or Participation credit.
*Please note: The maximum number of credits is calculated based on attending all live sessions. View CME hours per session on the program here.
FINANCIAL DISCLOSURES
The planners and faculty for this activity did not have any relationships to disclose unless listed here. All relevant relationships were mitigated prior to the start of the activity according to ACCME Standards.
DISCLOSURE OF COMMERCIAL SUPPORT
The American Headache Society® received support for this activity from the following organizations:
AbbVie
Lundbeck LLC
Pfizer Inc.
Available Credit
- 30.75 AAFP
- 25.25 ABPN Self-Assessment
- 25.25 AMA PRA Category 1 Credit™
- 25.25 Participation